๐ฐ Memory Disorders Program News
Page 2 - Memory Disorders Program News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Memory Disorders Program. Real-time updates on events, politics, business and more.
October 24, 2022
Medically reviewed by Dr. Ari Magill First described by Alois Alzheimer in 1906, Alzheimer's disease (AD) is a ...
June 7, 2022
07.06.2022 - BOTHELL, Wash., June 07, 2022 (GLOBE NEWSWIRE) - Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced the ... Seite 1
October 8, 2021
There are over five million Americans struggling with dementia and the numbers are expected to rise as the aging population grows.
January 21, 2021
Published: Jan 20, 2021 CLARKSVILLE, Md., Jan. 20, 2021 (GLOBE NEWSWIRE) -- Neuronascent Inc., a privately-held neuron regeneration therapeutics company, today announced the publication of results of their novel pharmacotherapy: NNI-362 to allosterically stimulate neural regeneration in human cultures and in vivo models of aging and disease. This small molecule therapy is presently in Phase 1 clinical trial for mild to moderate Alzheimerโs disease (AD), which is supported by a NIA R01 g...